Welcome back to Stockhouse Member Sign In
Sign in with one of the following accounts.
Send my password
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Use one of the following accounts.
WF10 (TM) doesn't achieve statistical significance over placebo arm in allergy trials
Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.
While gold/silver drill results grabbed the attention of some speculators Monday
WF10 Fails Phase 2 Allergic Rhinitis Study By Jason Napodano, CFA On January 30, 2015, Nuvo Research Inc. (NRI.TO) announced results of...
I caught it. It was short. One guy from Zacks asked a couple questions. No other questions were asked. A few points I remember off the...
Statiscally, you can Phil. But the null is not whether the placebo is significantly better than zero. The null is that the treated...
I was sleeping in this morning safe in knowing the results were not due out until the middle of February. Obviously I missed the...